[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA881756B - Inactivation of human immunodeficiency virus(hiv)in protein-containing solutions by phenols - Google Patents

Inactivation of human immunodeficiency virus(hiv)in protein-containing solutions by phenols

Info

Publication number
ZA881756B
ZA881756B ZA881756A ZA881756A ZA881756B ZA 881756 B ZA881756 B ZA 881756B ZA 881756 A ZA881756 A ZA 881756A ZA 881756 A ZA881756 A ZA 881756A ZA 881756 B ZA881756 B ZA 881756B
Authority
ZA
South Africa
Prior art keywords
hiv
inactivation
immunodeficiency virus
human immunodeficiency
protein
Prior art date
Application number
ZA881756A
Other languages
English (en)
Inventor
Hilfenhaus Joachim
Original Assignee
Behringwerke Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Aktiengesellschaft filed Critical Behringwerke Aktiengesellschaft
Publication of ZA881756B publication Critical patent/ZA881756B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16061—Methods of inactivation or attenuation
    • C12N2740/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA881756A 1987-03-12 1988-03-11 Inactivation of human immunodeficiency virus(hiv)in protein-containing solutions by phenols ZA881756B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873707987 DE3707987A1 (de) 1987-03-12 1987-03-12 Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole

Publications (1)

Publication Number Publication Date
ZA881756B true ZA881756B (en) 1988-08-31

Family

ID=6322881

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881756A ZA881756B (en) 1987-03-12 1988-03-11 Inactivation of human immunodeficiency virus(hiv)in protein-containing solutions by phenols

Country Status (13)

Country Link
US (1) US4886779A (xx)
EP (1) EP0281978B1 (xx)
JP (1) JPH07106985B2 (xx)
AT (1) ATE88752T1 (xx)
AU (1) AU613603B2 (xx)
CA (1) CA1340414C (xx)
DE (2) DE3707987A1 (xx)
DK (1) DK135588A (xx)
ES (1) ES2054719T3 (xx)
FI (1) FI881123A (xx)
IE (1) IE61439B1 (xx)
MX (1) MX164795B (xx)
ZA (1) ZA881756B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022742A (en) 1986-11-26 2000-02-08 Kopf; Henry B. Culture device and method
FR2662353A1 (fr) * 1990-05-22 1991-11-29 Neyroud Andre Savon en pain ou liquide antiseptique puissant, qui detruit les virus du sida, assure l'hygiene corporelle et protege la peau.
GB9110808D0 (en) * 1991-05-17 1991-07-10 Retroscreen Ltd Aids vaccine and method for its production
DE10112617A1 (de) * 2001-03-14 2002-10-02 Aventis Behring Gmbh Verwendung eines C1-Esterase-Inhibitors zur Verhinderung oder Verzögerung der Abstoßung von Xenotransplantaten in Säugetieren
EP2719704B1 (en) * 2011-04-08 2016-07-20 Universidad De Costa Rica Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL63957C (xx) * 1946-01-03
DE2643213C2 (de) * 1976-09-25 1985-02-21 Bayer Ag, 5090 Leverkusen Verfahren zum Abschwächen oder Inaktivieren von Mikroorganismen
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4713240A (en) * 1985-04-04 1987-12-15 Research Corporation Vaccines based on insoluble supports
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)
WO1988009655A1 (en) * 1987-06-05 1988-12-15 Al Sioufi Habib Method and device for disinfecting biological fluids and container for same
US4833165A (en) * 1987-10-07 1989-05-23 Louderback Allan Lee Method of inactivating HTLV-III virus in blood

Also Published As

Publication number Publication date
JPH07106985B2 (ja) 1995-11-15
IE880725L (en) 1988-09-12
JPS63243023A (ja) 1988-10-07
MX164795B (es) 1992-09-24
DK135588D0 (da) 1988-03-11
EP0281978A3 (en) 1990-01-24
IE61439B1 (en) 1994-11-02
AU613603B2 (en) 1991-08-08
FI881123A0 (fi) 1988-03-10
US4886779A (en) 1989-12-12
DK135588A (da) 1988-09-13
FI881123A (fi) 1988-09-13
CA1340414C (en) 1999-03-02
ES2054719T3 (es) 1994-08-16
AU1303788A (en) 1988-09-15
ATE88752T1 (de) 1993-05-15
EP0281978B1 (de) 1993-04-28
DE3707987A1 (de) 1988-09-22
DE3880533D1 (de) 1993-06-03
EP0281978A2 (de) 1988-09-14

Similar Documents

Publication Publication Date Title
HK45193A (en) Ozone decontamination of blood and blood products
ZA931035B (en) Sulfonic acid derivatives in the treatment of viral diseases.
ATE77554T1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
GR3006807T3 (xx)
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
ZA881756B (en) Inactivation of human immunodeficiency virus(hiv)in protein-containing solutions by phenols
AU2567888A (en) Hiv peptides and methods for detection of hiv
GB9417249D0 (en) A novel salt
UA13377A (uk) Спосіб одержаhhя противірусhого засобу
GR3014952T3 (en) Use of an immunoglobulin-containing composition in the prophylaxis and therapy of AIDS of human.
ES2006632A6 (es) Procedimiento de tratamiento termico de fibrinogeno.
EP0323157A3 (en) Antiviral compounds and methods
FR2458068B1 (xx)
AU7514087A (en) Vaccine containing the protein f of the aids virus
EP0249167A3 (en) Process for preparing a pasteurized immunoglobulin preparation
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours
IL90783A0 (en) Antiviral method for human immuno deficiency virus
ATE76302T1 (de) Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus.
SU1797350A1 (ru) Способ обнаружения вируса иммунодефицита человека
ES2008625A6 (es) Procedimiento para la obtencion de concentrados de aminoacidos; solubles y de alto grado de pureza, a partir de subproductos proteicos animales.